ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

https://www.uni-ulm.de/med/fakultaet/med-detailseiten/news-detail/article/rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv/

Most Recent Papers

Exciton transport enhancement across quantum Su-Schrieffer-Heeger lattices with quartic nonlinearity, Physical Review B, 100, 104307 (2019)

Hybrid spatiotemporal architectures for universal linear optics, Physical Review A, 99, 062301 (2019)

Quantum Kibble-Zurek physics in long-range transverse-field Ising models, Physical Review A, 100, 032115 (2019)

Contact

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm
Germany

Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924

Office: Building O25, room 410

Click here if you are interested in applying to the group